Intra-Cellular Therapies Inc. buy TD Cowen
Start price
11.12.23
/
50%
€55.30
Target price
11.12.24
€69.65
Performance (%)
14.83%
Price
14.06.24
€63.50
Summary
This prediction is currently active. The BUY prediction by TD_Cowen currently has a performance of 14.83%. This prediction currently runs until 11.12.24. The prediction end date can be changed by TD_Cowen at any time. TD_Cowen has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intra-Cellular Therapies Inc. | 0.000% | 0.000% |
iShares Core DAX® | -2.926% | -4.228% |
iShares Nasdaq 100 | 4.462% | 8.605% |
iShares Nikkei 225® | 0.306% | 0.284% |
iShares S&P 500 | 2.488% | 4.773% |
Comments by TD_Cowen for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at TD Cowen. They set an "outperform" rating and a $75.00 price target on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by TD_Cowen for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.50
18.04.24
18.04.24
€84.35
18.04.25
18.04.25
-7.30%
14.06.24
14.06.24